Search for Clinical Trial Results

Sponsored By

Azotemia - 25 Studies Found

Status Study
Completed Study Name: Sensitivity and Specificity of NGAL in an Emergency Room Population
Condition:
  • Azotemia
  • Renal Insufficiency, Chronic
  • Drug: Azithromycin ZITHROMAX &
Completed Study Name: Haemolytic Uraemic Syndrome in Childhood: Clinical, Cognitive and Psychological Aspects
Condition:
  • Hemolytic-Uremic Syndrome
  • Children
  • Parents
  • Date: 2012-07-31
Recruiting Study Name: Study of 'Vascular Competence' Profile and Endothelial Activation in the Hemolytic Uremic Syndrome in Children and Adults
Condition: Hemolytic Uremic Syndrome
Date: 2016-09-08
Interventions: Biological: Extra blood draw samples
Recruiting Study Name: Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHU
Condition: Hemolytic Uremic Syndrome of Childhood
Date: 2014-07-28
Interventions:
  • Drug: Eculizumab

Terminated Study Name: Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome
Condition: Hemolytic Uremic Syndrome
Date: 1999-10-18
Interventions:
  • Drug: SYNSORB Pk Other Name: O
Completed Study Name: Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4
Condition:
  • Hemolytic-uremic Syndrome
  • Escherichia Coli Infections

Date: 2011-07-28
Interventions: Other: HUS standard coverage care (including in ICU) HUS standard coverage care : plasmaphereses - eculi
Not yet recruiting Study Name: Study of ALXN1210 in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS)
Condition: Atypical Hemolytic Uremic Syndrome (aHUS)
Date: 2017-04-24
Interventions: Biological: ALXN1210 Single loading dose on Day 1, followed by regular maintenance dosing beginning on D
Recruiting Study Name: Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Condition: Atypical Hemolytic Uremic Syndrome (aHUS)
Date: 2016-10-25
Interventions: Biological: ALXN1210 Single loading dose on Day 1, followe
Recruiting Study Name: Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUS
Condition: Atypical Hemolytic Uremic Syndrome
Date: 2015-10-05
Interventions: Drug: eculizumab eculizumab discontinuation
Next >>>